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Objective: To assess cognitive performance and psychosocial functioning in patients with bipolar
disorder (BD), in unaffected siblings, and in healthy controls.
Methods: Subjects were patients with BD (n=36), unaffected siblings (n=35), and healthy controls
(n=44). Psychosocial functioning was accessed using the Functioning Assessment Short Test (FAST).
A sub-group of patients with BD (n=21), unaffected siblings (n=14), and healthy controls (n=22) also
underwent a battery of neuropsychological tests: California Verbal Learning Test (CVLT), Stroop Color
and Word Test, and Wisconsin Card Sorting Test (WCST). Clinical and sociodemographic charac-
teristics were analyzed using one-way analysis of variance or the chi-square test; multivariate analysis
of covariance was used to examine differences in neuropsychological variables.
Results: Patients with BD showed higher FAST total scores (23.90611.35) than healthy controls
(5.8665.47; p o 0.001) and siblings (12.60611.83; p 0.001). Siblings and healthy controls also
showed statistically significant differences in FAST total scores (p = 0.008). Patients performed worse
than healthy controls on all CVLT sub-tests (p o 0.030) and in the number of correctly completed
categories on WCST (p = 0.030). Siblings did not differ from healthy controls in cognitive tests.
Conclusion: Unaffected siblings of patients with BD may show poorer functional performance
compared to healthy controls. FAST scores may contribute to the development of markers of
vulnerability and endophenotypic traits in at-risk populations.
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Introduction
The high heritability of bipolar disorder (BD) has been
demonstrated in several twin and adoption studies.1 The
risk of first-degree relatives developing BD is approxi-
mately 10-fold higher than that of the general population.2
Despite the evidence supporting the existence of neuro-
biological trait abnormalities in individuals at genetic risk
for BD, most individuals with a family history of BD will not
develop the disorder.2 Conversely, they may present
subtle symptoms or vulnerabilities, which are less studied.
BD is associated with psychosocial functioning decline,
and greater impairment is commonly observed at later
stages of the illness.3 Functional disabilities in BD are not
limited to symptomatic periods; they may remain present
or result in sustained disability.4 In a follow-up study, after
two years, 98% of first-episode manic patients had
symptomatic recovery, whereas only 38% had functional
recovery.5 Therefore, the inability of patients with BD to
function socially and occupationally and to live indepen-
dently is not necessarily associated with symptom
status.5
Neurocognitive deficits have been consistently corre-
lated with functional impairment in BD and have been
pointed out as one of the most relevant predictors of
functionality in BD.6-8 Patients with poor functioning have
been shown to present poorer cognitive performance,
particularly in verbal memory and executive function,
even when euthymic.6,7,9-11 Forcada et al.8 emphasized
that intelligence quotient (IQ), total white matter volume,
and course of depressive illness were independently
associated with functional outcome in patients (assessed
with the Global Assessment of Functioning Scale), but not
in relatives (siblings and offspring). Studies with first-
episode manic patients have consistently shown deficits
in visual, verbal, and working memory when compared to
healthy controls.12,13
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Some studies have suggested the presence of cognitive
dysfunction in unaffected first-degree relatives of patients
with BD when compared to healthy controls, particularly in
executive function and/or verbal memory.14-16 Arts et al.,14
in a meta-analysis, showed a small effect size (do 0.500)
for executive function and verbal memory parameters in
first-degree relatives.
Moreover, there is evidence supporting the existence of
neurobiological trait abnormalities in individuals at genetic
risk for BD.17 A systematic review of neuroimaging studies
involving individuals at high genetic risk for BD (twins,
siblings, offspring, first-degree, and second-degree rela-
tives of patients) found accumulating structural and
functional imaging evidence suggesting abnormalities in
this population.17
Even though BD has a strong genetic underpinning, little
is known about clinical or biological features associated
with risk for the illness. In this sense, a better understanding
of the familial risk for BD in siblings and of how this familial
risk is clinically manifested could help researchers identify
heritable sub-phenotypes of the disorder, as this population
has high genetic loading for BD because of the shared
DNA. It may also shed light on the pathophysiology of the
condition, and possibly encourage further research into the
genetic architecture of BD.
Therefore, the objective of this study was to investigate
the presence of neurocognitive and functioning impairment
in patients with BD, in unaffected siblings, and in healthy
controls, comparing siblings to the two other groups, in an
attempt to characterize neuropsychological performance and
psychosocial functioning in a Brazilian population at genetic
risk of developing BD. Considering that cognitive deficits are
one of the most relevant predictors of functioning in BD, we
thought it would be interesting to asses cognitive perfor-
mance and functioning in unaffected siblings. We hypothe-
sized that patients with BD and unaffected siblings would
show impaired performance on cognitive and psychosocial
functioning tests when compared with healthy controls.
Methods
Participants
This is a cross-sectional study reporting data obtained at
the Bipolar Disorder Program, at Hospital de Clı´nicas de
Porto Alegre (HCPA), Universidade Federal do Rio Grande
do Sul, southern Brazil. Participants included outpatients
receiving a diagnosis of BD type I at the program, one or
more unaffected siblings of each patient included, and
healthy controls. Thirty-six patients with BD, 39 unaffected
siblings, and 44 healthy subjects were included. All patients
were tested for mood symptoms and psychosocial function-
ing; a subgroup of 21 patients, 14 siblings, and 22 healthy
controls underwent a battery of neuropsychological tests.
Inclusion criteria for patients were: having a diagnosis of BD
type I according to the Structured Clinical Interview for
DSM-IV Axis I Disorders (SCID-I), being on current phar-
macological treatment, being euthymic for at least 45 days,
presenting scores p 7 on the Hamilton Depression
Rating Scale (HDRS). and the Young Mania Rating Scale
(YMRS), not having neurological diseases or severe clinical
illnesses, having siblings without a diagnosis of BD, and
agreeing to participate in the study.
Siblings were included if they did not have a psychiatric
diagnosis according to DSM-IV, if they scored p 7 on
HDRS and YMRS, did not have neurological diseases or
severe clinical illnesses, and if they agreed to participate in
the study.
Finally, controls were volunteer blood donors invited and
recruited at the Blood Bank of the HCPA. Inclusion criteria
for the control group were: not having a psychiatric diagnosis
according to DSM-IV, scoringp 7 on HDRS and YMRS, not
having neurological diseases or severe clinical illnesses,
having a negative psychiatric history, having a negative
family history of psychiatric disorders (considering all first
degree-relatives), and agreeing to participate in the study.
Individuals with unstable inflammatory diseases were
excluded. All controls underwent a comprehensive clinical
interview conducted by a well-trained psychiatrist, using a
short version of the SCID-I.
All the procedures described in this study were
approved by the local Research Ethics Committees.
Written informed consent was obtained from all the
participants prior to any study procedures.
Assessment
Depressive and manic symptoms were assessed using
HDRS and YMRS, respectively. Cognitive performance
was assessed with a focus on executive function and verbal
memory, areas that have been demonstrated to be relevant
in BD.18 Executive function was evaluated using the Stroop
Color and Word Test19 and the standard score of the
Wisconsin Card Sorting Test (WCST).20 Verbal memory
was measured using the California Verbal Learning Test
(CVLT).21
Psychosocial functioning was assessed using the Func-
tioning Assessment Short Test (FAST), a four-point Likert-
type scale containing 24 items whose scores may range
from 0 to 72; higher scores indicate poorer functional
status.22 The scale covers six specific areas of psychosocial
functioning: autonomy, occupational functioning, cognitive
functioning, financial issues, interpersonal relationships, and
leisure time. The FAST has been validated for use both in
the Brazilian population23 and in patients with BD,22 and has
been reported to be sensitive to change.24,25
Statistics
Statistical analyses were performed using the SPSS version
19.0. The three groups (patients, siblings, and healthy
controls) were compared with regard to clinical and socio-
demographic characteristics using either analysis of variance
or the chi-square test, as appropriate. Multivariate analysis of
covariance (MANCOVA) was performed to examine differ-
ences in neuropsychological variables between groups.
Cognitive variables were used as dependent variables,
mood symptoms (HDRS and YMRS results) as covariates,
and the group was the main factor. Comparisons showing
significant effects were further analyzed using MANCOVA
followed by Tukey’s honestly significant difference post-hoc
tests.
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Pearson’s correlation was used to evaluate the relation-
ship between functioning, cognitive variables, and clinical
variables in the group of patients with BD. A linear
regression model was used to identify the best predictors
of psychosocial functioning; all clinical variables showing
correlation with FAST scores were tested. All analyses
were two-tailed. Significance was set at p o 0.050.
Results
Thirty-six patients with BD, 39 unaffected siblings, and
44 healthy subjects were included in the study. Socio-
demographic variables and mood rating scale scores are
shown in Table 1. Variables, including gender, age, and
years of education were not significantly different between
patients, siblings, and control groups.
Patients, siblings, and healthy controls all showed very
low sub-threshold symptoms, as indicated by mood rating
scale scores. However, there were statistical differences
in depressive and manic symptom scores between
patients and healthy controls (p o 0.010) and between
siblings and healthy controls (p o 0.010). As expected,
patients with BD showed higher FAST total scores
(23.91611.35) when compared to both healthy controls
(5.8665.48; p o 0.001) and siblings (12.60611.83; p o
0.001). Siblings and healthy controls also showed
statistical differences in FAST total scores (p = 0.008).
Patients also showed higher functional impairment than
healthy controls when FAST domains were analyzed
separately (all p o 0.004). When compared with siblings,
patients showed higher functional impairment in the
autonomy (pp 0.001), occupational (pp 0.001), cognition
(p = 0.004), financial (p = 0.030), and interpersonal
relationships (p = 0.010) domains. There were also
statistical differences between siblings and healthy con-
trols, with siblings showing higher impairment in cognition
(p = 0.010), interpersonal relationships (p = 0.003), and
leisure time (p = 0.040). FAST scores obtained for all three
groups are shown in Table 2.
Because the groups differed in terms of HDRS scores,
MANCOVA was used to control for potential confounders,
using the group as the main factor. The analysis revealed
significant differences in functioning between the groups,
even when HDRS was used as a covariate (Pillai’s F =
3.620, degrees of freedom [df] = 2, p p 0.001).
Neuropsychological results are shown in Table 3.
MANCOVA (Pillai’s F = 1.481, df = 2, p o 0.001) was
performed for the main effect and revealed significant
differences in cognitive performance between the groups.
Patients performed worse than both healthy controls and
siblings on all CVLT sub-tests (all p o 0.010). Executive
function showed significant differences between patients
and healthy controls in the number of correctly completed
categories on WCST (p = 0.030). The same pattern was
found when HDRS and YMRS scores were used as
covariates in MANCOVA. Medications currently in use by
the patients who performed neuropsychological tests are
shown in Table 1.
Correlations were found between CVLT long delayed
free recall and HDRS (r = -0.44, p = 0.020), and between
CVLT total recall and HDRS (r = -0.51, p p 0.010). There
were also significant positive correlations between FAST
total scores and HDRS (r = 0.65, p o 0.001), number of
previous depressive episodes (r = 0.55, p = 0.002), number
of previous manic episodes (r = 0.63, p o 0.001), and
number of previous hospitalizations (r = 0.38, p = 0.03).
Finally, in the linear regression model, HDRS scores,
number of depressive episodes, number of psychiatric
hospitalizations, and number of manic episodes were
entered simultaneously as predictors into a regression
equation using FAST total scores as the dependent
measure. Only HDRS scores remained a significant
predictor of FAST total scores (B = 1.81, standard error
= 0.57, p = 0.004).
Table 1 Demographic and clinical characteristics of patients with BD, unaffected siblings, and healthy controls
Characteristics Patients (n=36) Siblings (n=39) Controls (n=44) p-value
Age (years)* 47.25 (10.16) 49.76 (15.02) 45.84 (12.15) 0.359
HDRS score* 4.11 (2.94) 3.59 (3.50) 0.70 (1.15) 4 0.001
YMRS score* 0.94 (1.53) 0.10 (1.53) 0.09 (0.36) 0.001
Sexw 0.134
Male 9 (25.00) 12 (30.76) 20 (45.45)
Female 27 (75.00) 27 (69.23) 24 (54.54)
Illness duration= 19.78 (11.54)
Current medicationsy
Lithium 14 (58.33)
Valproic acid 12 (50.00)
Typical antipsychotics 2 (8.34)
Atypical antipsychotics 12 (50.01)
Antidepressants 2 (8.34)
Benzodiazepines 3 (12.51)
Data presented as mean (standard deviation) or n (%).
BD = bipolar disorder; HDRS = Hamilton Depression Rating Scale; YMRS = Young Mania Rating Scale.
*p-value by ANOVA.
w p-value by chi-square test.
= Illness duration calculated considering age at diagnosis of BD.
yMedications currently in use by patients who completed the neuropsychological battery (n=21).
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Discussion
To the authors’ knowledge, this is the first study to
compare cognitive performance and psychosocial func-
tioning between patients with BD, unaffected siblings, and
healthy controls. The findings of this research can be
summarized as follows: 1) there were significant differ-
ences in memory tasks and executive function between
patients and healthy controls, but not between siblings
and controls; 2) patients showed higher functional
impairment according to FAST scores compared to both
healthy controls (all domains) and unaffected siblings
(some domains); 3) there were statistical differences
between siblings and healthy controls in FAST total
scores and in specific domains of the scale, namely,
cognition, interpersonal relationships, and leisure time.
With regard to patients and healthy controls, our
findings are consistent with previous studies that have
shown higher cognitive impairment, in particular in
executive function and verbal memory, in remitted
patients with BD compared to controls,7,10,11 as well as
greater functioning impairment in patients vs. healthy
controls.3
However, our study also showed poorer psychosocial
functioning in unaffected siblings of patients with BD
compared to healthy controls, as measured by the FAST.
To our knowledge, this is the first study to evaluate
psychosocial functioning in siblings using this instrument.
Linnen et al.,26 Ellenbogen et al.,27 and Ostiguy et al.28
investigated psychosocial functioning in the offspring of
patients with BD, but those authors evaluated specifically
interpersonal relationships; all three studies found some
degree of impairment in the domain assessed. Bella
et al.29 evaluated other areas in addition to interpersonal
relationships in children of patients with BD, and also
found impairment. However, we could not find other
studies assessing psychosocial functioning in unaffected
siblings of patients with BD.
The FAST scores obtained in the present study placed
siblings in an intermediate position between patients with
BD and healthy controls, suggesting that psychosocial
functioning could be either an endophenotypic trait or a
sign of vulnerability and/or resilience in this population.
Rosa et al.3 found higher FAST scores in late-stage BD
patients than in early-stage patients, and suggested that
FAST scores could have the potential to distinguish
between patients in early vs. late stages of BD. We could
speculate that the results obtained with siblings in the
present study are consistent with the staging model of BD
- siblings might have a so-called latent-stage BD,30 as a
Table 2 Psychosocial functioning as assessed by specific FAST domains in patients with BP, unaffected siblings, and healthy
controls
FAST Patients* (n=33) Siblingsw (n=35) Controls (n=43) F/p-value=
Total score 23.91 (11.35) 12.60 (11.83) 5.86 (5.48) 32.01/o 0.001
Autonomy 3.41 (2.85) 1.26 ( 2.47) 0.63 (1.04) 15.80/o 0.001
Occupational 5.38 (4.79) 1.69 (2.55) 0.86 (1.39) 21.20/o 0.001
Cognitive 6.47 (3.49) 4.11 (3.11) 2.14 (2.29) 19.83/o 0.001
Financial 1.94 (2.09) 0.97 (1.58) 0.53 (0.85) 7.81/0.001
Interpersonal relationships 4.69 (3.05) 2.86 (3.37) 0.79 (1.47) 19.72/o 0.001
Leisure time 2.03 (1.59) 1.71 (1.84) 0.91 (0.97) 5.89/0.004
Data presented as mean (standard deviation).
BD = bipolar disorder; FAST = Functioning Assessment Short Test.
*Patients showed higher functional impairment than healthy controls (all po 0.004), higher impairment than unaffected siblings in autonomy
(p = 0.001), occupational functioning (p o 0.001), cognition (p = 0.004), financial (p = 0.03), and interpersonal relationships (p = 0.01).
wUnaffected siblings showed higher impairment than healthy controls in cognition (p = 0.01), interpersonal relationships (p = 0.003), and
leisure time (p = 0.04).
= p-value by ANOVA.
Table 3 Cognitive performance of patients with BD, unaffected siblings, and healthy controls
Patients (n=21) Siblings (n=14) Controls (n=22) ANOVA F/p-value Post-hoc
CVLT total recall 42.61 (10.57) 50.56 (8.07) 51.65 (10.75) 5.45/0.007 P o HC, S*
CVLT short delayed free recall 1 8.22 (2.96) 10.89 (2.11) 11.39 (2.65) 9.40/o 0.001 P o HC, Sw
CVLT long delayed free recall 2 8.78 (2.84) 11.11 (2.65) 10.11 (2.97) 5.63/0.006 P o HC, S=
CVLT short delayed cued recall 1 9.43 (2.46) 11.50 (1.65) 11.65 (2.55) 6.45/0.003 P o HC, Sy
CVLT long delayed cued recall 2 9.22 (2.71) 11.78 (2.13) 11.70 (2.40) 7.77/0.001 P o HC, S||
Stroop Color and Word Test 107.93 (69.13) 82.77 (19.05) 79.60 (56.81) 1.80/0.173 P = HC = S
WCST perseverative errors 83.61 (13.93) 80.06 (15.14) 88.13 (16.30) 1.46/0.240 P = S = HC
WCST number of correctly completed categories 2.70 (1.29) 2.89 (1.53) 3.74 (1.35) 3.62/0.033 P o HCz
Data presented as mean (standard deviation).
BD = bipolar disorder; CVLT = California Verbal Learning Test; HC = healthy controls; P = patients; S = siblings; WCST = Wisconsin Card
Sorting Test.
*p p 0.01 between patients and healthy controls, p = 0.01 between patients and unaffected siblings.
w p p 0.01 between patients and unaffected siblings, p o 0.01 between patients and healthy controls.
= p p 0.01 between patients and healthy controls, p p 0.01 between patients and unaffected siblings.
yp p 0.01 between patients and unaffected siblings, p p 0.01 between patients and healthy controls.
|| p p 0.01 between patients and unaffected siblings, p o 0 .01 between patients and healthy controls.
zp = 0.03 between patients and healthy controls.
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result of the biological underpinnings of BD that they
share. Conversely, it is also possible that the siblings
selected for the present study had a high level of
resilience, as they remained without psychiatric diagnosis
despite the genetic and environmental factors shared with
the patients. Of note, the mean age of siblings in our
sample was 45.6 years, which is beyond the first peak
age of BD onset (BD type I has two peaks of onset age,
the first at 15-24 years and the second at 45-54 years).31
Neurocognitive deficits in patients with BD, an estab-
lished part of the disorder, have been strongly correlated
with poor functioning6-8 and with other clinical factors,
such as disease severity, chronicity, and residual symp-
toms.9,32 Another study has shown that patients with
multiple-episode BD have poorer functioning, especially
in the FAST autonomy, occupational, interpersonal
relationships, and leisure time domains, compared to
first-episode patients.33 Finally, Forcada et al.8 showed
that IQ, total white matter volume, and a predominantly
depressive illness course were independently associated
with functional outcomes in patients with BD, but not in
their relatives.
In line with the findings described above, the present
study found poor cognition and functioning in patients with
BD. CVLT parameters in patients were different from
those obtained for controls and also for siblings, reinfor-
cing the effect of the disease on cognitive outcomes. This
finding highlights the damage caused by number of
episodes and number of hospitalizations, as suggested
by Strakowski et al.,34 who have shown abnormalities in
neural circuits involved in mood regulation and cognition
in multiple-episode patients. In the present study, CVLT,
Stroop Color and Word Test, and WCST results were
similar in siblings and controls.
There are studies reporting significant impairment of
verbal working memory in siblings of patients with BD
compared to healthy controls.35,36 Similar results have
been found in comparisons between first-degree relatives
(siblings, parents) and healthy controls.37,38 Conversely,
other authors have reported negative results for verbal
learning, with no differences between first-degree rela-
tives of patients with BD and healthy control groups.39,40
However, comparison across those studies is limited, as
samples are not homogenous with regard to the type and
age of first-degree relatives included (siblings, offspring,
and parents).
Kulkarni et al.35 assessed sample similar to ours, i.e.,
middle-aged siblings and controls. In that study, unaf-
fected siblings performed poorly on the Tower of London
Test (a planning test) and on Rey’s Auditory Verbal
Learning Test , but there were no significant differences
between siblings and healthy controls on the Stroop Color
and Word Test, the WCST, and the Iowa Gambling Task
(IGT). Nehra et al.36 also reported poor performance of
middle-aged unaffected siblings of patients with BD in
verbal learning tests, assessed using the Hopkins Verbal
Learning Test-Revised. Again, these controversial find-
ings reported for unaffected relatives may be explained
by heterogeneous samples (type and age of relative
assessed) and by methodological differences, e.g., in the
cognitive tests employed. Moreover, in our study, only a
sub-group of participants (smaller sample size) under-
went the neurocognitive test battery, reducing the power
to detect subtler impairments - which we would expect to
be the case with siblings, considering their intermediate
position between patients and controls in terms of
functional scores. Further studies are warranted to
assess cognitive reserve in siblings of patients with BD,
given the apparently relevant role played by this variable
in cognitive impairment in BD.32
Our findings need to be considered in light of two major
limitations: first, our small sample size; second, the cross-
sectional design of our study. It would be interesting to
see the effects of a larger sample and of a longitudinal
design on the results here reported.
In conclusion, the present study suggests that unaf-
fected siblings of patients with BD may have poorer
functional performance when compared to healthy con-
trols, probably as a result of the genetic background that
they share with the patients. The use of FAST scores may
contribute to the development of markers in at-risk
populations, and may be considered as an endopheno-
typic trait. It remains to be known whether the impairment
of psychosocial functioning found in unaffected siblings
has any effect on their quality of life. Further prospective
studies are needed to improve our knowledge in this area
and help identify endophenotypes.
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